Search research articles

Search research articles

Related Experiment Videos

Pleural mesothelioma.

¹Insitut Gustave Roussy, Villejuif, France.

Current Opinion in Oncology

|April 1, 1991

Summary

This summary is machine-generated.

Diffuse pleural mesotheliomas are malignant tumors linked to asbestos exposure. Despite various treatments, survival remains poor, highlighting the need for cooperative therapeutic trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026

Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026

Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026

Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026

Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026

Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Area of Science:

Oncology
Occupational Medicine

Background:

Pleural mesotheliomas, particularly diffuse types, are rare but malignant tumors.
They are strongly associated with occupational asbestos exposure, serving as a key indicator.
Incidence has risen due to historical asbestos use, with symptoms including chest pain and dyspnea.

Purpose of the Study:

To review the clinical features, diagnosis, prognosis, and therapeutic challenges of pleural mesothelioma.
To emphasize the link between asbestos exposure and mesothelioma development.
To discuss the need for collaborative research in therapeutic trials.

Main Methods:

Review of clinical features and diagnostic challenges.
Analysis of prognostic factors including performance status, stage, and asbestos exposure.

Related Experiment Videos

Evaluation of existing therapeutic modalities (surgery, radiotherapy, chemotherapy).

Main Results:

Malignant pleural mesothelioma has a poor prognosis with a median survival of 9-12 months.
Locoregional spread is common, but metastasis also occurs.
Prognostic factors include performance status, stage, platelet count, age, histology, and asbestos exposure.

Conclusions:

Distinguishing mesothelioma from metastatic adenocarcinoma is challenging, often requiring extensive biopsy and specialized techniques.
Current therapeutic modalities offer limited improvement in median survival.
Future therapeutic trials require cooperative efforts to address the tumor's rarity and prognostic diversity, comparing new therapies against best supportive care.